| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |